Gilde Healthcare

Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Lava Therapeutics B.V. is a biotechnology company based in Utrecht, the Netherlands, founded in 2016. The company specializes in developing proprietary bispecific antibodies aimed at engaging gamma-delta T cells for the treatment of both hematological and solid cancers. Its innovative platform, known as the Gammabody platform, is designed to create next-generation bispecific antibodies that activate the immune system to recognize and eliminate tumor cells. By harnessing the potential of γδ T cells, Lava Therapeutics aims to produce potent, safe, and cost-effective biopharmaceuticals that enhance the body's ability to combat cancer, thereby transforming the landscape of cancer treatment.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Lava Therapeutics B.V. is a biotechnology company based in Utrecht, the Netherlands, founded in 2016. The company specializes in developing proprietary bispecific antibodies aimed at engaging gamma-delta T cells for the treatment of both hematological and solid cancers. Its innovative platform, known as the Gammabody platform, is designed to create next-generation bispecific antibodies that activate the immune system to recognize and eliminate tumor cells. By harnessing the potential of γδ T cells, Lava Therapeutics aims to produce potent, safe, and cost-effective biopharmaceuticals that enhance the body's ability to combat cancer, thereby transforming the landscape of cancer treatment.

Performation Healthcare Intelligence specializes in providing business intelligence solutions tailored for the healthcare sector. The company offers software, data analysis, and consulting services aimed at helping healthcare organizations monitor costs, processes, and quality. With a team of over a hundred experienced consultants and experts in business intelligence, Performation enables clients to make informed decisions that enhance the delivery of effective and high-quality care. By addressing healthcare-wide informational challenges and integrating data into comprehensive information products, Performation has established itself as a prominent player in the Dutch market.

NIZO food research BV is an independent contract research organization based in Ede, the Netherlands, with additional offices in the United States, France, and Japan. Founded in 1948, NIZO specializes in providing research and innovation services to the dairy, food and beverage, ingredients, and biotech industries. The company focuses on developing new flavors and textures, utilizing advanced technologies to enhance food products while addressing sustainability, cost-effectiveness, and speed to market. NIZO's offerings include analysis, contract research, production services, webinars, white papers, training programs, and pre-competitive research. The company also operates a food-grade processing plant to bring innovative food technologies to life.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

Pharmaline is a young, innovative, semi-industrial compounding pharmacy, based in Oldenzaal. In 2009 they started with 30 employees; at this time that there are over 140. Their highly qualified company has been set up according to the latest GMP guidelines. They offer about 700 pharmacists in the Netherlands a rational and comprehensive range of pharmaceutical solutions, service and advice. Standardization, rationalization, knowledge and expertise are central, increasing the quality of care while reducing healthcare costs. Their mission is short and sweet: "Care for Saving lives and costs. Pharmaline offers the full package pharmacy compounding that is common in community pharmacies. This applies both to stock preparations as ad hoc preparations at the patient level in the form of creams, ointments, tablets, capsules, drops, liquids, suspensions, and injectabilia (injections, infusions, cassettes). You do not need to look where certain products are available; with us you can find all your pharmacy preparations! Their experienced pharmacists are daily available to advise you on rationality, pharmacotherapy, production engineering, application engineering and legislation. Of course they also have the most modern equipment.

Fysius Rugexperts operates a network of clinics in the Netherlands that specializes in treating lower back and related pain. Utilizing advanced treatment methods and innovative aids, such as the OriGENE device, Fysius employs the latest scientific insights to effectively address chronic back and spinal pain. With a focus on improving the health and fitness of its patients, the organization treats over 10,000 individuals annually, making it the largest and most specialized clinic for back pain in the country.

VerzuimVitaal is a Dutch provider of occupational health services that help companies manage employee absenteeism. VerzuimVitaal reduces the costs of absenteeism by increasing the vitality of client organizations and their employees. It also manages the process of sick leave and reintegration.